Skip to main content
FERMENTA BIOTECH LIMITED logo

FERMENTA BIOTECH LIMITED — Investor Relations & Filings

Ticker · FERMENTA ISIN · INE225B01021 LEI · 335800VNTNWW8G1U9314 BSE.NS Manufacturing
Open in API
Filings indexed 671 across all filing types
Latest filing 2019-10-01 Regulatory Filings
Country IN India
Listing BSE.NS FERMENTA

About FERMENTA BIOTECH LIMITED

https://fermentabiotech.com

Fermenta Biotech Limited is a specialized biotechnology company primarily focused on the development and manufacture of Vitamin D3 (Cholecalciferol). As one of the few vertically integrated manufacturers globally, the company produces Vitamin D3 for diverse applications, including pharmaceuticals, dietary supplements, human nutrition, and animal feed. Beyond its core Vitamin D3 portfolio, the company offers a range of specialty enzymes, particularly for the synthesis of beta-lactam antibiotics, and provides environmental solutions through its biotechnology expertise. Fermenta Biotech emphasizes high-quality standards, maintaining various international certifications for its manufacturing facilities. Its product offerings extend to premixes and value-added formats designed to meet specific formulation requirements. The company serves a global clientele, leveraging its research and development capabilities to innovate in the fields of nutrition and biotechnology.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation to our intimation vide letter ....
Regulatory Filings
2019-10-01 English
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting ....
Investor Presentation Classification · 90% confidence The document is a short notice informing the stock exchange about scheduled meetings with analysts and institutional investors, pursuant to SEBI regulations. It mentions that an Investor Presentation for August 2019 has been uploaded on the company's website and the exchange's website. The document itself does not contain the presentation or detailed financial data but serves as an announcement of the upcoming investor interaction and the availability of the presentation elsewhere. The length is short (1819 characters), and it is primarily an announcement rather than the presentation itself. Therefore, according to the MENU VS MEAL RULE, this document should be classified as an Investor Presentation (IP) announcement. However, since it is notifying about the schedule and availability of the presentation rather than the presentation content itself, it fits best under Investor Presentation (IP) category as it relates directly to investor communication and presentation materials.
2019-09-30 English
Pursuant to the provisions of Regulation 30 of Listing Regulations, we wish to inform that the Board of Directors at its meeting held on September 26, 2019, inter alia, approved the following: ....
Regulatory Filings
2019-09-26 English
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting ....
Investor Presentation Classification · 95% confidence The document is a short notice informing about the schedule of meetings with analysts and institutional investors, referencing an Investor Presentation dated August 2019. It states that the presentation has been uploaded on the company's website and BSE website. The document is an announcement of the upcoming investor interaction and the availability of the presentation, not the presentation itself. The length is only 1840 characters, which is short and consistent with an announcement rather than a full report. Therefore, this fits the category of an Investor Presentation announcement or notification. According to the filing definitions, the best match is 'Investor Presentation (IP)' since it specifically mentions the presentation to investors and analysts and provides details about the meeting schedule and presentation availability.
2019-09-26 English
We are pleased to inform you that the Mumbai Bench of the National Company Law Tribunal has conveyed its approval for the Scheme of Amalgamation of Fermenta Biotech Limited (The Transferor ....
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the listing department of a stock exchange, disclosing the approval of a Scheme of Amalgamation by the National Company Law Tribunal. It references regulatory compliance under SEBI Listing Obligations and Disclosure Requirements, specifically Regulation 30, which pertains to material event disclosures. The document does not contain financial statements or detailed financial analysis but is an announcement of a corporate event (amalgamation approval). The document length is short (1978 characters) and it serves as a disclosure notice rather than a full report or detailed filing. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for regulatory announcements that do not fit other specific categories.
2019-09-25 English
Pursuant to the relevant provisions of SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, we would like to inform you that the officials of the Company will be interacting ....
Investor Presentation Classification · 95% confidence The document is a short notice informing the stock exchange about the schedule of meetings with analysts and institutional investors. It references the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and mentions that an Investor Presentation for August 2019 has been uploaded on the company's website and the BSE website. The document does not contain the presentation itself or detailed financial data, but rather announces the upcoming interaction and availability of the presentation elsewhere. The document length is only 1843 characters, which is quite short and consistent with an announcement rather than a full report. Therefore, this document is best classified as an Investor Presentation announcement or notification. According to the filing definitions, the Investor Presentation (IP) category fits best as it is about the presentation for investors focusing on financials, strategy, and market position, even though the presentation itself is not included here, the document is about the presentation meeting and its schedule. Confidence is high due to clear references and document content.
2019-09-11 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.